Expect a cannabis sector sell-off over the next few weeks, says Raymond James analyst Rahul Sarugase... Read More
Start your engines, folks, Canadian cannabis stocks are about to take off. That’s the word from Ra... Read More
The race is on for cannabis companies to take a slice of the US$40-billion biosynthesis pie, says Ra... Read More
The advent of biosynthetic cannabis will be a boost for Canadian licensed producer Cronos Group (Cro... Read More
Despite ongoing murkiness in the US CBD market, stocks like Cronos Group (Cronos Group Stock Quote, ... Read More
Raymond James analyst Rahul Sarugaser has made an unusual comparison, likening cannabis player Crono... Read More